FDA Adverse Event Injury Summary report: N

TOTAL ASR ACET IMP SIZE 56

MDR report key: 3140002 · Received May 31, 2013

Report

Report Number
1818910-2013-06326
Event Type
Injury
Date Received
May 31, 2013
Date of Event
March 26, 2013
Report Date
September 1, 2015
Manufacturer
DEPUY INTERNATIONAL LTD - 8010379
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA. (B)(4).

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Description of Event or Problem · 1

UPDATE 3 SEPTEMBER 2015: UPDATED HIP SIDE TO RIGHT HIP. UPDATED TO LEGAL AND ATTACHED LEGAL CLAIM. UPDATED REASONS FOR REVISION TO INCLUDE IMPLANT NOISE (SQUEAK), ELEVATED COBALT & CHROMIUM LEVELS & METALLOSIS. ADDED PATIENT'S NAME AND DATE OF BIRTH, UPDATED GENDER. ADDED PRIMARY SURGERY HOSPITAL. ADDED KENNEDYS DETAILS AS COMPLAINANT. ADDED MANUFACTURE AND EXPIRY DATES FOR PRODUCTS. TAKEN FROM NEW ASR LEGAL CLAIM 2 SEPTEMBER 2015.

Description of Event or Problem · 1

ASR REVISION; ASR XL; REASON FOR REVISION - UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
241225 TOTAL ASR ACET IMP SIZE 56 HIP ACETABULAR CUP KWA DEPUY INTERNATIONAL LTD - 8010379 2185354

Patients

Seq Age Sex Outcome Treatment
1 52 YR Required Intervention